Riggs Josh — SEC Form 4 filings

SEC reporting owner CIK 1956391. 5 Form 4 filings on record with FilingPulse; latest filed 2026-03-30.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-04-15 to 2026-03-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Insight Molecular Diagnostics Inc. (IMDX)CEO and President, Director51 leg · 3,390 sh · $10,0006

Form 4 filings — Riggs Josh

FiledFormIssuerReported transactionsSource
2026-03-304Insight Molecular Diagnostics Inc. (IMDX)Option exercise (M): 47,170 · Tax withholding (F): 12,310 @ $4.11 · Option exercise (M): 47,170 (derivative) @ $0EDGAR
2025-09-304Insight Molecular Diagnostics Inc. (IMDX)Grant/award (A): 400,000 (derivative) @ $0EDGAR
2025-03-284Oncocyte Corp (OCX)Grant/award (A): 188,679 (derivative) @ $0EDGAR
2024-05-224Oncocyte Corp (OCX)Grant/award (A): 90,000 (derivative) @ $0EDGAR
2024-04-154Oncocyte Corp (OCX)Purchase (P): 3,390 @ $2.95EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1956391 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →